Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2025

Accounting Policies [Abstract]

Schedule of Significant Segment Expenses

In addition to net loss, the CODM is also provided information on certain significant segment expenses which are presented below:

	Three Months Ended March 31,
	2025		2024
Revenues:	$	926,932	$	628,601
Expenses:
Medical expenses (less depreciation and equity-based compensation)	819,715		572,033
Selling, general, and administrative expenses (less equity-based compensation)	87,796		70,791
Other segment expenses (1)	24,825		26,925
Interest expense	3,950		5,427
Net loss	$	(9,354)	$	(46,575)

(1) Other segment items included in segment net income includes equity-based compensation, depreciation and amortization, other expenses (income), and provision for income taxes.

Schedule of Earned Revenue

Earned premium revenue consisted of premium revenue and capitation revenue for the three months ended March 31, 2025 and 2024 were as follows:

	Three Months Ended March 31,
	2025		2024
Premium	$	916,622	$	619,722
Capitation	1,421		1,834
Total	$	918,043	$	621,556

Schedule of Property and Equipment

Depreciation expense is computed using the straight-line method generally based on the following estimated useful lives:

Description	Estimated Service Lives (years)
Computer and equipment	5
Office equipment and furniture	5-7
Software	3-5
Leasehold improvements	15 (or lease term, if shorter)

Property and equipment consisted of the following as of March 31, 2025 and December 31, 2024:

	March 31, 2025		December 31, 2024
Computers and equipment	$	12,723	$	12,569
Office equipment and furniture	4,341		4,341
Software	184,548		179,336
Leasehold improvements	6,231		6,231
Construction in progress	17,009		14,049
Subtotal	224,852		216,526
Less accumulated depreciation	(156,348)		(149,387)
Property and equipment-net	$	68,504	$	67,139

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2025 and 2024:

	Three Months Ended March 31,
	2025		2024
Numerator:
Net loss	$	(9,354)	$	(46,575)
Less: Net loss attributable to noncontrolling interests	240		54
Net loss attributable to Alignment Healthcare, Inc.	$	(9,114)	$	(46,521)
Denominator:
Total weighted-average common shares outstanding - basic and diluted	193,653,028		189,597,668
Less: Restricted shares of common stock	(46,590)		(592,274)
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic and diluted	193,606,438		189,005,394
Net loss per share:
Net loss per share - basic and diluted	$	(0.05)	$	(0.25)

Schedule of Computation of Diluted Net Loss Per Share

In addition to the restricted shares of common stock, we also excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share as of March 31, 2025 and 2024:

	March 31,
	2025	2024
Stock options	8,717,493	9,023,343
Restricted stock units	17,187,135	22,767,035
Convertible senior notes	25,720,959	—
Total	51,625,587	31,790,378